ORBIMED ADVISORS LLC - 11 Aug 2025 SCHEDULE 13D/A Report for ArriVent BioPharma, Inc. Common Stock (AVBP)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
ORBIMED ADVISORS LLC
Security
ArriVent BioPharma, Inc. Common Stock
Symbol
AVBP
Shares outstanding
40,364,373 shares
Disclosed Ownership
3,027,328 shares
Ownership
7.5%
Form type
SCHEDULE 13D/A
Filing time
13 Aug 2025, 19:43:50 UTC
Date of event
11 Aug 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ORBIMED ADVISORS LLC 7.5% 3,027,328 0 3,027,328 /s/ Carl L. Gordon Member 0001055951
OrbiMed Capital GP VIII LLC 3.7% 1,513,664 0 1,513,664 /s/ Carl L. Gordon Member of OrbiMed Advisors LLC 0001845804
OrbiMed Asia GP IV, L.P. 3.7% 1,513,664 0 1,513,664 /s/ Carl L. Gordon Director of OrbiMed Advisors IV Limited 0001966836
OrbiMed Advisors IV Limited 3.7% 1,513,664 1,513,664 0 /s/ Carl L. Gordon Director 0001966835